Published in J Chemother on December 01, 1989
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer (2002) 2.34
Antimicrobial activity of certain Indian medicinal plants used in folkloric medicine. J Ethnopharmacol (2001) 1.83
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol (1989) 1.69
Passive avoidance in syndromes of disinhibition: psychopathy and extraversion. J Pers Soc Psychol (1985) 1.48
Spinal aspergillus abscess in a patient with bronchocentric granulomatosis. J Intensive Care Med (1995) 1.39
A novel method for laparoscopic placement of Tenckhoff peritoneal dialysis catheters. BJU Int (2003) 1.38
The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. J Biol Chem (2000) 1.32
Predictors of success in surgical ligation of painful varicocele. Urol Int (2007) 1.21
Low PSA metastatic androgen- independent prostate cancer. Eur Urol (2000) 1.20
PAGET'S DISEASE AND MALE BREAST CANCER. Isr Med Assoc J (2015) 1.08
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin. Br J Cancer (1991) 1.02
The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel. Br J Cancer (2001) 1.01
Clinical diagnosis of secondary tumors of the heart and pericardium. Dis Chest (1969) 1.00
Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys (1999) 0.99
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol (1989) 0.98
Second neoplasms in patients with Merkel cell carcinoma. Cancer (2001) 0.98
The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer (1997) 0.96
Novel peptides that inhibit the propagation of Newcastle disease virus. Arch Virol (2002) 0.92
5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage. Oncology (1989) 0.92
Hemoglobin S-C disease revisited: clinical study of 106 adults. Am J Hematol (2001) 0.91
Therapeutic irradiation of the chest and electrocardiographic changes. Clin Radiol (1969) 0.91
Decline in pulmonary function in patients with breast cancer receiving dose-dense chemotherapy: a prospective study. Ann Oncol (2009) 0.91
Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer. Int J Gynecol Cancer (2001) 0.90
Clinical studies of liposome-encapsulated doxorubicin. Acta Oncol (1994) 0.90
A new human ovarian carcinoma cell line: establishment and analysis of tumor-associated markers. Oncology (1985) 0.90
Phase I and clinical pharmacological evaluation of aphidicolin glycinate. J Natl Cancer Inst (1991) 0.90
Tritiated thymidine labeling index and response in human breast cancer. J Natl Cancer Inst (1979) 0.89
[Solitary metastatic involvement of the spleen in squamous cell carcinoma of the cervix]. Harefuah (1977) 0.89
Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials Group. Ann Oncol (1994) 0.88
The management of pericardial effusion in cancer patients. Chest (1977) 0.88
Correlation of erythrocyte and plasma levels of zinc, copper, and iron with evidence of metastatic spread in cancer patients. Cancer (1985) 0.87
Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial. Oncol Rep (2001) 0.87
High-density lipoprotein and extracellular matrix promotes growth and plating efficiency of normal human mammary epithelial cells in serum-free medium. Int J Cancer (1983) 0.87
Estimation of creatinine clearance without 24-hour urine collection--a useful guide during cisplatin therapy. Acta Oncol (1993) 0.87
The mechanism of human bladder tumor implantation in an in vitro model. J Urol (1986) 0.87
Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel. Am J Clin Oncol (1998) 0.87
Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (1995) 0.86
Colorectal cancer in young patients in Israel: a distinct clinicopathological entity? World J Surg (2010) 0.86
Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512). Cancer Res (1988) 0.85
Isolated pericardial metastasis of parotid tumor origin. Head Neck Surg (1982) 0.85
Effect of beta-blocking drug propranolol on 131 I utilization in euthyroid patients. J Clin Pharmacol New Drugs (1972) 0.84
Pericardial effusion as first evidence of malignancy in bronchogenic carcinoma. J Surg Oncol (1982) 0.84
Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers. Br J Cancer (2002) 0.83
A sequential four-drug chemotherapy and biotherapy with interferon alpha and GM-CSF--an innovative protocol for the treatment of metastatic melanoma. Cancer Biother Radiopharm (1998) 0.83
Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. J Clin Psychopharmacol (1989) 0.83
Spontaneous pneumothorax complicating lung metastases from carcinoma of the breast. Radiol Clin (Basel) (1977) 0.83
Sex hormone binding globulin (SHBG) in breast cancer: a correlation with obesity but not with estrogen receptor status. Eur J Cancer Clin Oncol (1984) 0.83
Metastatic bone involvement in gynecological malignancies. Radiol Clin (Basel) (1978) 0.83
Amitriptyline and haloperidol in unstable and schizotypal borderline disorders. Psychopharmacol Bull (1986) 0.83
Inhibition of macromolecular synthesis in cultured macrophages by Pseudomonas pseudomallei exotoxin. Microbiol Immunol (1989) 0.82
Prognosis of patients with recurrent laryngeal carcinoma. Head Neck (2001) 0.82
Reappraisal of some dosage adjustment guidelines. Cancer Treat Rep (1987) 0.82
Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. Transplantation (1996) 0.82
Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases. Br J Cancer (2001) 0.82
Second primary lung carcinoma. J Surg Oncol (1980) 0.81
Parameters affecting the in vitro maturation of human monocytes to macrophages. Int J Cell Cloning (1986) 0.81
Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry (1993) 0.81
The expression of xenobiotic-metabolizing enzymes in human prostate and in prostate epithelial cells (PECs) derived from primary cultures. Prostate (2006) 0.81
Thyroid carcinoma induced by irradiation for Hodgkin's disease. Report of a case. Acta Radiol Oncol Radiat Phys Biol (1978) 0.81
Breast cancer arising in surgical scars. J Surg Oncol (1976) 0.81
Combined 5-fluorouracil (5-FU) and radiation therapy following resection of locally advanced gastric carcinoma. J Surg Oncol (1986) 0.81
Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20). Eur J Immunol (1986) 0.81
Influence of propranolol on serum thyroxine in the rat. J Endocrinol (1972) 0.80
Familial nephritis. Isr J Med Sci (1967) 0.80
Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer. Br J Cancer (2001) 0.80
Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines. Int J Oncol (1999) 0.80
The carcinomatous neuropathy. A clinical and electro-physiological comparative study, with special reference to the effect of treatment on the nervous system. Eur Neurol (1970) 0.80
Coronary artery operation in patients after breast cancer therapy. Ann Thorac Surg (1998) 0.80
Involvement of heparanase in tumor metastasis and angiogenesis. Isr J Med Sci (1989) 0.80
Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma. J Clin Oncol (1988) 0.79
Letter: Breast cancer arising in thoracotomy scars. Lancet (1976) 0.79
Synthesis and receptor-binding affinity of fluorotamoxifen, a possible estrogen-receptor imaging agent. J Med Chem (1985) 0.79
Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial. J Urol (2005) 0.79
Aminoglutethimide-induced leukopenia: a case report and review of the literature. Oncology (1984) 0.79
Antibiotic prophylaxis for bilateral sagittal split osteotomies: a randomized, double-blind clinical study. Int J Oral Maxillofac Surg (2012) 0.78
Antiandrogen withdrawal syndrome with cyproterone acetate. Urology (1998) 0.78
Comment on "Perhaps not everyone knows that...", (Ann Oncol 2001; 12: 1186). Ann Oncol (2002) 0.78
Second-line chemotherapy with mitoxantrone as a single agent in metastatic breast cancer. J Chemother (1993) 0.78
Growth of human mammary carcinoma cells from biopsy specimens in serum-free medium on extracellular matrix. Int J Cancer (1986) 0.78
Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer. Biomed Pharmacother (1988) 0.78
Current concepts in cancer: ovary--treatment for stages III and IV. The multimodal approach to the treatment of stage III ovarian carcinoma. Int J Radiat Oncol Biol Phys (1982) 0.78
Corticosteroids in radiation-induced pericarditis. Chest (1978) 0.78
Platelet-tumor cell interaction with the subendothelial extracellular matrix: relationship to cancer metastasis. Radiother Oncol (1985) 0.78
Cyclophosphamide, adriamycin, DTIC and vincristine with methotrexate in the treatment of advanced soft tissue sarcomas. Isr J Med Sci (1989) 0.78
HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities. J Clin Pathol (2000) 0.78
The treatment of advanced Merkel cell carcinoma. A multimodality chemotherapy and radiation therapy treatment approach. J Dermatol Surg Oncol (1993) 0.78
Radiation therapy for locally advanced breast cancer: prognostic factors and complication rate. Eur J Surg Oncol (1990) 0.78
Prevention of human bladder tumor cell implantation in an in vitro assay. J Urol (1987) 0.78
Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients. Bone Marrow Transplant (2003) 0.78
The use of cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of Merkel cell carcinoma. Am J Clin Oncol (1993) 0.78
Construction and characterization of recombinant single-chain variable fragment antibodies against Toxoplasma gondii MIC2 protein. Parasitology (2005) 0.78
Adjuvant chemotherapy with and without radiotherapy in stage II breast cancer. Biomed Pharmacother (1988) 0.78
Detection of different interleukin-1 activities in human monocytes and monocytic cell lines. J Biol Response Mod (1986) 0.78
Vocal acoustics in the endangered proboscis monkey (Nasalis larvatus). Am J Primatol (2013) 0.78